Metformin and Sibutramine+[Cellulose microcrystallic] [set] (active substance) - analogs
Components: Metformin || Sibutramine |
|||||||||
| Prices in pharmacies: Instructions Metformin and Sibutramine+[Cellulose microcrystallic] [set] | |||||||||
|
ⓘ✘Enter drugs for checking interactions through a quick button search . Metoprolol tartrate ✘ (incl) Sulpiride ✘ |
|
ⓘ✘ diseases to evaluate contraindications and side effects through a quick search. | ||||||
Начиная работу с сервисом, вы принимаете соглашение пользователя. Kiberis do not replace the doctor!
Metformin and Sibutramine+[Cellulose microcrystallic] [set] included in the composition |
Prices in pharmacies |
-
Similar
Prices in
pharmaciesAnalogs by action ⓘ✘Analogues of the drug according to its degree of similarity with other drugs that are not direct analogues
- 52% Metformin+Sitagliptin Dangerous 🔍 [Metformin and more 1Sitagliptin]
- 52% Alogliptin+Metformin Dangerous 🔍 [Alogliptin and more 1Metformin]
- 52% Vildagliptin+Metformin Dangerous 🔍 [Vildagliptin and more 1Metformin]
- 50% Sibutramine+[Cellulose microcristallic] neutral [Sibutramine]
- 50% Dapagliflozin+Metformin Dangerous 🔍 [Dapagliflozin and more 1Metformin]
- 50% Linagliptin+Metformin Dangerous 🔍 [Linagliptin and more 1Metformin]
- 50% Metformin+Empagliflozin Dangerous 🔍 [Metformin and more 1Empagliflozin]
- 50% Metformin+Rosiglitazone Dangerous 🔍 [Metformin and more 1Rosiglitazone]
- 50% Gosogliptine and Metformin Dangerous 🔍 [Gosogliptine and more 1Metformin]
- 50% Glimepiride+Metformin Dangerous 🔍 [Glimepiride and more 1Metformin]
- 50% Metformin+Saxagliptin Dangerous 🔍 [Metformin and more 1Saxagliptin]
- 50% Metformin+Glipizide Dangerous 🔍 [Metformin and more 1Glipizide]
- 48% Glibenclamide+Metformin Dangerous 🔍 [Glibenclamide and more 1Metformin]
- 48% Metformin+Glibenclamide Dangerous 🔍 [Metformin and more 1Glibenclamide]
- 47% Gliclazide+Metformin Dangerous 🔍 [Gliclazide and more 1Metformin]
- 38% Alogliptin+Pioglitazone neutral [Alogliptin and more 1Pioglitazone]
- 36% Metformin Dangerous 🔍
- 33% Crospovidone neutral
- 33% Linagliptin+Empagliflozin neutral [Linagliptin and more 1Empagliflozin]
- 32% Glimepiride+Rosiglitazone Dangerous 🔍 [Glimepiride and more 1Rosiglitazone]
- 32% Nateglinide neutral
- 29% Insulin aspart biphasic Dangerous 🔍
- 27% Insulin-aminoquinuride [pork monocomponent] Dangerous 🔍
- 27% Glibenclamide Dangerous 🔍
- 27% Insulin soluble [human semisynthetic] Dangerous 🔍
- 27% Gliclazide Dangerous 🔍
- 26% Insulin biphasic [human biosynthetic] Dangerous 🔍
- 26% Glipizide Dangerous 🔍
- 26% Metformin hydrochloride neutral
- 23% Vildagliptin neutral
- 23% Alogliptin neutral
- 23% Pioglitazone neutral
- 23% Gemigliptin neutral
- 23% Buformin Dangerous 🔍
- 22% Insulin-isophan [human biosynthetic] Dangerous 🔍
- 22% Insulin-isophan [pork monocomponent] Dangerous 🔍
- 20% Empagliflozin neutral
- 20% Canagliflozin neutral
- 20% Dapagliflozin neutral
- 20% Gosogliptine neutral
- 20% Evogliptin neutral
- 20% Acarbose neutral
- 20% Exenatide neutral
- 20% Linagliptin neutral
- 20% Chlorpropamide Dangerous 🔍
- 20% Rosiglitazone neutral
- 20% Dapagliflozin+Saxagliptin neutral [Dapagliflozin and more 1Saxagliptin]
- 20% Miglitol neutral
- 20% Gliquidone Dangerous 🔍
- 20% Insulin degludec Dangerous 🔍
Learn more about the selection of analogues
- The drug has «Metformin and Sibutramine+[Cellulose microcrystallic] [set]» 51 analog by action, the most similar - Metformin+Sitagliptin .
- Medical online service has selected the best substitutes for Metformin and Sibutramine+[Cellulose microcrystallic] [set] based on its instructions, components, pharmaceutical groups and practical application.
- The table shows the prices of analogues Metformin and Sibutramine+[Cellulose microcrystallic] [set] to choose the cheapest pills.
- If you have introduced other drugs for registration, substitutes are selected taking into account the assessment of interactions and safety.
- Sometimes, due to the presence of dangerous interactions, it is necessary to use drugs that are similar in effect, sometimes even from different pharmacological groups.